CD37 Biosimilar Antibody

• Catalog Number: orb1173653
• Category: Antibodies
• Description: Anti-CD37 (naratuximab biosimilar) mAb
• Target: CD37
• Clonality: Monoclonal
• Species/Host: Chimeric
• Isotype: IgG1
• Conjugation: Unconjugated
• Reactivity: Human
• Form/Appearance: Powder
• Purification: Purified from cell culture supernatant by affinity chromatography
• UniProt ID: P11049
• Tested applications: FC
• Dilution range: Flow Cyt 1:100
• Application notes: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
• Antibody Type: Biosimilar Antibody
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Alternative names: CD37TSPAN26Tspan-26
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

HEK293 cell line transfected with irrelevant protein (B) and human CD37 (A) were surface stained with Anti-CD37 mAb 1 μg/ml (naratuximab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.

Flow cytometry analysis of antigen binding of anti-human CD37 mAb (orb1173653). (A) orb1173653 does not bind to 293T cells that do not express CD37. (B) A clear peak shift of orb1173653 was seen compared to the control when incubated with CD37-expressing THP-1 cells, indicating strong binding of orb1173653 to CD37. Antibodies were incubated at 5 μg/mL.